查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790122

美國醫療旅遊市場規模、佔有率和趨勢分析報告：按類型、消費行為、主要企業、競爭分析和細分預測，2025-2023 年

U.S. Medical Tourism Market Size, Share & Trends Analysis Report By Type (Inbound Medical Tourism, Outbound Medical Tourism), Consumer Behavior, Key Companies, Competitive Analysis, And Segment Forecasts, 2025 - 203
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國醫療旅遊市場規模及趨勢：

美國醫療旅遊市場規模預計在 2024 年達到 87.4 億美元，預計到 2033 年將達到 265.8 億美元，預測期內複合年成長率為 13.20%。

近年來，受國際認證醫院數量的不斷成長及其提供尖端治療的聲譽的推動，醫療市場經歷了顯著成長。美國醫療機構越來越重視以患者為中心的個人化護理，這是該國醫療旅遊業發展的主要驅動力。

醫院和診所越來越注重根據患者的個別需求量身定做治療方案，提供個人化護理計劃，並提升患者的整體體驗。這種高品質、以患者為中心的醫療服務預計將受到尋求更個人化醫療方案的國際患者的熱烈追捧。

美國擁有眾多獲得國際認證的醫院，這推動了入境醫療旅遊的成長。隨著全球患者在醫療保健決策中越來越重視安全性、品質和透明度，美國正透過提供符合嚴格國際標準的醫療機構，將自己定位為首選目的地。根據美國國際患者計畫合作協會 (USCIPP) 2023 年的報告，60 家美國機構在一個財政年度內為 47,002 名國際患者累計了服務，總合收入達 21 億美元。此外，獲得國際聯合委員會 (JCI)、全球醫療保健認證 (GHA) 和挪威船級社 (DNV-GL) 等全球公認機構認證的醫院在競爭激烈的醫療旅遊市場中脫穎而出，讓患者對醫療品質和診療流程的完整性感到安心。

此外，擁有國際培訓經驗的醫生對支持美國入境醫療旅遊的發展發揮關鍵作用。這些醫生通常被稱為國際醫學畢業生 (IMG)，構成了美國醫療保健團隊的重要組成部分。根據《住院醫師雜誌》(The Hospitalist) 報道，到 2023 年，美國約有 25% 的在職醫師將是 IMG。這些醫生來自印度、巴基斯坦和奈及利亞等多個國家，擁有豐富的臨床專業知識和多語言能力。這些素質增強了臨床團隊的實力，並創造了文化敏感的醫療環境，這對於尋求個人化、貼心醫療體驗的國際患者尤其重要。

此外，美國醫療旅遊的主要驅動力之一是該國極高的醫療成本。根據美國醫療保險和醫療補助服務中心 (CMS) 的數據，到 2022 年，美國全國醫療支出將達到 4.5 兆美元，人均約 13,493 美元，約佔 GDP 的 17.3%。這些數字顯示美國醫療保健的巨大經濟負擔。

同時，根據美國人口普查局的數據，到2023年，大約8%的美國人口仍然沒有保險，92%的人口將擁有保險。即使是那些有保險的人，也經常會遇到高額的免賠額、共同支付或共同保險，這使得許多重要的治療在經濟上難以承受。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國醫療旅遊：市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 商業環境分析工具
    • 波特五力分析
    • PESTLE分析

第4章：美國入境醫療旅遊市場分析

  • 2018-2030年美國入境醫療旅遊市場規模預測
    • 監管和報銷情況
    • 2024入境治療/程序分析（程序類型）
    • 2024 年住院病患分析 (%) (病患來源)
    • 2018年至2030年住院病患分析（人數）
    • 2024年每位患者的平均支出

第5章 競爭分析

  • 公司分類
  • 企業市場分析
  • 戰略地圖
  • 公司簡介/上市公司
    • Cleveland Clinic
    • Mayo Clinic
    • The Johns Hopkins Hospital
    • Cedars-Sinai
    • Massachusetts General Hospital
    • UCSF Health
    • NewYork-Presbyterian Hospital
    • Ronald Reagan UCLA Medical Center
    • Northwestern Memorial Hospital
    • Stanford Health Care

第6章美國出境醫療旅遊：市場變數、趨勢與範圍

  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 商業環境分析工具
    • 波特五力分析
    • PESTLE分析

第7章美國出境醫療旅遊市場分析

  • 2018-2030年美國出境醫療旅遊市場規模預測
  • 2018-2030年各國情況
    • 墨西哥
    • 加拿大
    • 印度
    • 哥斯大黎加
    • 泰國
    • 巴西
    • 其他國家
    • 門診治療及手術分析（手術類型）2024
    • 2018年至2030年門診病人分析（患者人數）

第8章美國出境醫療旅遊市場：保險覆蓋範圍

  • 出境醫療旅遊醫療保險覆蓋率：定性分析

第9章美國出境醫療旅遊市場：策略框架

  • 策略舉措
  • 促進國際醫療旅遊的夥伴關係和合作
  • 吸引美國病患的美國境外主要國際醫院
Product Code: GVR-4-68038-096-5

U.S. Medical Tourism Market Size & Trends:

The U.S. medical tourism market size was estimated at USD 8.74 billion in 2024 and is projected to grow at a CAGR of 13.20% over the forecast period to reach an estimated value of USD 26.58 billion by 2033. The market has experienced significant growth in recent times, driven by the increasing presence of internationally accredited hospitals and the reputation for providing cutting-edge medical treatments. The growing emphasis on personalized and patient-centric care in U.S. healthcare facilities is significantly driving the medical tourism industry in the country.

Hospitals and clinics increasingly focus on tailored treatments to individual patient needs, providing personalized care plans, and enhancing the overall patient experience. This high-quality, patient-centered care is expected to witness high demand from international patients seeking an advanced and customized approach to their health.

The presence of internationally accredited hospitals in the U.S. is driving the growth of the inbound medical tourism. As global patients increasingly prioritize safety, quality, and transparency in their healthcare decisions, the U.S. has positioned itself as a preferred destination by offering facilities that meet stringent international standards. As per the 2023 report by The U.S. Cooperative for International Patient Programs (USCIPP), 60 different U.S. organizations assisted 47,002 international patients and reported gross revenue charges totaling USD 2.1 billion in a single fiscal year. Furthermore, hospitals accredited by globally recognized organizations such as Joint Commission International (JCI), Global Healthcare Accreditation (GHA), and DNV-GL stand out in a competitive medical tourism landscape, offering reassurance to patients regarding care quality and procedural integrity.

Moreover, the presence of internationally trained physicians plays a significant role in supporting the growth of the U.S. inbound medical tourism industry. These physicians, commonly referred to as International Medical Graduates (IMGs), comprise a substantial portion of the national medical workforce. According to The Hospitalist, in 2023, nearly 25 percent of active physicians in the U.S. were IMGs. These physicians originate from a wide range of countries, including India, Pakistan, and Nigeria, and bring with them diverse clinical expertise and multilingual capabilities. These qualities strengthen the clinical workforce and foster a culturally sensitive care environment that is especially valuable for international patients seeking personalized and familiar care experiences.

Furthermore, one of the primary drivers of outbound medical tourism from the U.S. is the exceptionally high cost of healthcare domestically. According to the Centers for Medicare & Medicaid Services (CMS), U.S. national health expenditures reached USD 4.5 trillion in 2022, averaging approximately USD 13,493 per person, accounting for about 17.3 percent of GDP. These figures underscore the steep financial burden of healthcare in the U.S.

Meanwhile, the U.S. Census Bureau reports that roughly 8 percent of the U.S. population remained uninsured in 2023, with a similar proportion, 92 percent, insured at some point during the year. Even those who are insured often encounter high deductibles, copayments, or coinsurance, making many vital treatments financially inaccessible.

U.S. Medical Tourism Market Report Segmentation

This report forecasts revenue growth, country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. medical tourism market report based on type.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Inbound Medical Tourism
  • Outbound Medical Tourism

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
    • 1.2.1 Information procurement
      • 1.2.1.1 Purchased database
    • 1.2.2 GVR's internal database
      • 1.2.2.1 Secondary sources
      • 1.2.2.2 Primary research
  • 1.3 Information or Data Analysis
    • 1.3.1 Data Analysis Models
  • 1.4 Market Formulation & Validation
  • 1.5 Model Details
    • 1.5.1 Bottom Up Approach
      • 1.5.1.1 Market Estimation Framework
        • 1.5.1.1.1. Pillar I - Secondary Research
        • 1.5.1.1.2. Pillar II - Primary Research
        • 1.5.1.1.3. Pillar III - Internal Benchmarking and Modeling
      • 1.5.1.2 Segmented Estimation Approach
        • 1.5.1.2.1. Inbound Medical Tourism Estimation
        • 1.5.1.2.2. Outbound Medical Tourism Estimation
      • 1.5.1.3 Forecasting Methodology (2025 - 2030)
  • 1.6 List of Secondary Sources
  • 1.7 List of Abbreviations
  • 1.8 Objectives
    • 1.8.1 Objective - 1
    • 1.8.2 Objective - 2
    • 1.8.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Market Segmentation
  • 2.3 Competitive Landscape

Chapter 3 U.S. Inbound Medical Tourism: Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Presence of International Accreditation Hospitals
        • 3.2.1.1.1. Case Study: Impact of Hospital Accreditation on Medicare Patient Outcomes in the U.S.
      • 3.2.1.2 Presence of internationally trained physicians
        • 3.2.1.2.1. Case Study: Comparative Patient Outcomes Between U.S.-Trained and Foreign-Trained Physicians
      • 3.2.1.3 Access to Advanced Medical Technology and Treatments
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Cost of Procedures
      • 3.2.2.2 Follow-Up Problems
    • 3.2.3 Market Opportunity Analysis
      • 3.2.3.1 Partnerships with International Insurers and Governments
    • 3.2.4 Market Challenges Analysis
      • 3.2.4.1 Visa and Immigration Barriers
  • 3.3 Business Environment Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 PESTLE Analysis

Chapter 4 U.S. Inbound Medical Tourism Market Analysis

  • 4.1 U.S. Inbound Medical Tourism Market Estimates & Forecasts, 2018 to 2030 (USD Million)
    • 4.1.1 Regulatory & Reimbursement Scenario
      • 4.1.1.1 Regulatory Framework
      • 4.1.1.2 Reimbursement Scenario
    • 4.1.2 Inbound Treatments/Procedures Analysis, 2024 (Type of Procedures)
    • 4.1.3 Inbound Patient Analysis, 2024 (%) (Patient Origin)
    • 4.1.4 Inbound Patient Traffic Analysis, 2018 - 2030 (Number of Patients)
    • 4.1.5 Average Spend Per Patient, 2024

Chapter 5 Competitive Analysis

  • 5.1. Company Categorization
  • 5.2. Company Market Position Analysis
  • 5.3. Strategy Mapping
  • 5.4. Company Profiles/Listing
    • 5.1.1. Cleveland Clinic
      • 5.1.1.1. Overview
      • 5.1.1.2. Financial Performance
      • 5.1.1.3. Service Benchmarking
      • 5.1.1.4. Strategic Initiatives
    • 5.1.2. Mayo Clinic
      • 5.1.2.1. Overview
      • 5.1.2.2. Financial Performance
      • 5.1.2.3. Service Benchmarking
      • 5.1.2.4. Strategic Initiatives
    • 5.1.3. The Johns Hopkins Hospital
      • 5.1.3.1. Overview
      • 5.1.3.2. Financial Performance
      • 5.1.3.3. Service Benchmarking
      • 5.1.3.4. Strategic Initiatives
    • 5.1.4. Cedars-Sinai
      • 5.1.4.1. Overview
      • 5.1.4.2. Financial Performance
      • 5.1.4.3. Service Benchmarking
      • 5.1.4.4. Strategic Initiatives
    • 5.1.5. Massachusetts General Hospital
      • 5.1.5.1. Overview
      • 5.1.5.2. Financial Performance
      • 5.1.5.3. Service Benchmarking
      • 5.1.5.4. Strategic Initiatives
    • 5.1.6. UCSF Health
      • 5.1.6.1. Overview
      • 5.1.6.2. Financial Performance
      • 5.1.6.3. Service Benchmarking
      • 5.1.6.4. Strategic Initiatives
    • 5.1.7. NewYork-Presbyterian Hospital
      • 5.1.7.1. Overview
      • 5.1.7.2. Financial Performance
      • 5.1.7.3. Service Benchmarking
      • 5.1.7.4. Strategic Initiatives
    • 5.1.8. Ronald Reagan UCLA Medical Center
      • 5.1.8.1. Overview
      • 5.1.8.2. Financial Performance
      • 5.1.8.3. Service Benchmarking
      • 5.1.8.4. Strategic Initiatives
    • 5.1.9. Northwestern Memorial Hospital
      • 5.1.9.1. Overview
      • 5.1.9.2. Financial Performance
      • 5.1.9.3. Service Benchmarking
      • 5.1.9.4. Strategic Initiatives
    • 5.1.10. Stanford Health Care
      • 5.1.10.1. Overview
      • 5.1.10.2. Financial Performance
      • 5.1.10.3. Service Benchmarking
      • 5.1.10.4. Strategic Initiatives

Chapter 6 U.S. Outbound Medical Tourism: Market Variables, Trends & Scope

  • 6.1 Market Dynamics
    • 6.1.1 Market Driver Analysis
      • 6.1.1.1 High Cost of Medical Treatments
      • 6.1.1.2 Longer Waiting Time
      • 6.1.1.3 Limited Insurance Coverage for Some Procedures
    • 6.1.2 Market Restraint Analysis
      • 6.1.2.1 Medical Risks Associated with Medical Tourism
      • 6.1.2.2 Follow-Up Problems
    • 6.1.3 Market Opportunity Analysis
      • 6.1.3.1 Improved Quality and Infrastructure in Destination Countries
    • 6.1.4 Market Challenges Analysis
      • 6.1.4.1 Limited Legal Recourse and Liability Protection
  • 6.2 Business Environment Analysis Tools
    • 6.2.1 Porter's Five Forces Analysis
    • 6.2.2 PESTLE Analysis

Chapter 7 U.S. Outbound Medical Tourism Market Analysis

  • 7.1 U.S. Outbound Medical Tourism Market Estimates & Forecasts, 2018 to 2030 (USD Million)
      • 7.1.1.1 U.S. Outbound Medical Tourism market, 2018 - 2030 (USD Million)
  • 7.2 U.S. Outbound Medical Tourism Market Estimates & Forecasts, by Country, 2018 to 2030 (USD Million)
    • 7.2.1 Mexico
      • 7.2.1.1 Mexico Market, 2018 - 2030 (USD Million)
    • 7.2.2 Canada
      • 7.2.2.1 Canada Market, 2018 - 2030 (USD Million)
    • 7.2.3 India
      • 7.2.3.1 India Market, 2018 - 2030 (USD Million)
    • 7.2.4 Costa Rica
      • 7.2.4.1 Costa Rica Market, 2018 - 2030 (USD Million)
    • 7.2.5 Thailand
      • 7.2.5.1 Thailand Market, 2018 - 2030 (USD Million)
    • 7.2.6 Brazil
      • 7.2.6.1 Brazil Market, 2018 - 2030 (USD Million)
    • 7.2.7 Rest of World
      • 7.2.7.1 Rest of World Market, 2018 - 2030 (USD Million)
    • 7.2.8 Outbound Treatments/Procedures Analysis, 2024 (Type of Procedures)
    • 7.2.9 Outbound Patient Traffic Analysis, 2018 - 2030 (Number of Patients)

Chapter 8 U.S. Outbound Medical Tourism Market: Insurance Coverage

  • 8.1 Medicare Coverage for Outbound Medical Tourism: Qualitative Analysis
    • 8.1.1 Medicare Coverage for Healthcare Services in Foreign Hospitals
    • 8.1.2 Services Covered by Medicare
    • 8.1.3 Services Not Covered by Medicare
    • 8.1.4 Medicare Supplement Insurance (Medigap)
    • 8.1.5 Medicare Health Plans Other Than Original Medicare

Chapter 9 U.S. Outbound Medical Tourism Market: Strategic Framework

  • 9.1 Strategic Initiatives
  • 9.2 Partnerships & Collaborations Encouraging Outbound Medical Tourism
  • 9.3 Leading Non-U.S. Based International Hospitals Attracting U.S. Patients

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 Average cardiovascular treatment price range comparison
  • TABLE 4 U.S. inbound patient traffic analysis, 2018 - 2030
  • TABLE 5 Approximate medical procedure cost comparison between the mentioned destinations (USD)
  • TABLE 6 Global JCI-accredited hospitals
  • TABLE 7 Savings comparison on medical procedures and travel times
  • TABLE 8 Average bariatric treatment price range comparison
  • TABLE 9 Average orthopedic treatment price range comparison
  • TABLE 10 Average cosmetic treatment price range comparison
  • TABLE 11 Average orthopedic treatment price range comparison with India
  • TABLE 12 Average orthopedic treatment price range comparison with Costa Rica
  • TABLE 13 U.S. average ophthalmology treatment price range comparison with Thailand
  • TABLE 14 U.S. average cosmetic treatment price range comparison with Brazil
  • TABLE 15 U.S. outbound patient traffic analysis, 2018 - 2030
  • TABLE 16 Leading non-U.S. based international hospitals

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain-based sizing & forecasting
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market snapshot
  • FIG. 9 Market segmentation
  • FIG. 10 Competitive landscape
  • FIG. 11 U.S. inbound medical tourism market dynamics
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 U.S. inbound medical tourism market: Porter's five forces analysis
  • FIG. 15 U.S. inbound medical tourism market: PESTLE analysis
  • FIG. 16 U.S. inbound medical tourism market estimates & forecasts, 2018 to 2030 (USD Million)
  • FIG. 17 U.S. inbound treatments/procedures analysis, 2024 (Type of procedures)
  • FIG. 18 U.S. inbound patient analysis, 2024 (%) (Patient origin)
  • FIG. 19 Company/competition categorization
  • FIG. 20 Company market position analysis
  • FIG. 21 Strategy mapping
  • FIG. 22 U.S. outbound medical tourism market dynamics
  • FIG. 23 Market driver relevance analysis (Current & future impact)
  • FIG. 24 Market restraint relevance analysis (Current & future impact)
  • FIG. 25 U.S. outbound medical tourism market: Porter's five forces analysis
  • FIG. 26 U.S. outbound medical tourism market: PESTLE analysis
  • FIG. 27 U.S. outbound medical tourism market, 2018 - 2030 (USD Million)
  • FIG. 28 Mexico market, 2018 - 2030 (USD Million)
  • FIG. 29 Canada market, 2018 - 2030 (USD Million)
  • FIG. 30 India market, 2018 - 2030 (USD Million)
  • FIG. 31 Costa Rica market, 2018 - 2030 (USD Million)
  • FIG. 32 Thailand market, 2018 - 2030 (USD Million)
  • FIG. 33 Brazil market, 2018 - 2030 (USD Million)
  • FIG. 34 Rest of World market, 2018 - 2030 (USD Million)
  • FIG. 35 U.S. outbound treatments/procedures analysis, 2024 (Type of procedures)